According the firms, the IDEX is a well managed company, with strong fundamental growth prospects. The firms are positive about IDEX as its backlog continues to build, its free cash flow generation remains strong and the Company has a healthy balance sheet and diverse niche business portfolio. But the firms are concerned about some of the partially recovered key end markets, the impact of the translation of quotes to sales, multiple near-term constraints given a lack of deal flow of late and global macro uncertainty. The firms prefer to remain on the sidelines and wait for a better entry point.